BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ly294002

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one [Supplementary Concept] specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

11+ PubMed studies analyzed · Evidence Score: 29.6

Research Domains

Ly294002 has been studied across 8 research domains including 🔬 Oncology, 🦴 Bone & Joint, 🧬 Hormones, 🔬 Inflammation, 🌤️ Mood & Depression. The primary research focus is 🔬 Oncology with 36% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ly294002, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

ly
17 shared targets
Wortmannin
15 shared targets
alpelisib
12 shared targets
Sirolimus
15 shared targets
torin
13 shared targets
pictilisib
20 shared targets
buparlisib
7 shared targets
Emodin
15 shared targets
Rotenone
13 shared targets
zstk
6 shared targets
Loading evidence profile...

This evidence profile for Ly294002 is generated deterministically from 11 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.